Evaluation of Antifungal Activity of Medicinal Plant Extracts Against Oral Candida albicans and Proteinases

dc.creatorHofling, JF
dc.creatorMardegan, RC
dc.creatorAnibal, PC
dc.creatorFurletti, VF
dc.creatorFoglio, MA
dc.date2011
dc.dateAUG
dc.date2014-07-30T17:27:53Z
dc.date2015-11-26T16:43:10Z
dc.date2014-07-30T17:27:53Z
dc.date2015-11-26T16:43:10Z
dc.date.accessioned2018-03-28T23:28:05Z
dc.date.available2018-03-28T23:28:05Z
dc.identifierMycopathologia. Springer, v. 172, n. 2, n. 117, n. 124, 2011.
dc.identifier0301-486X
dc.identifierWOS:000293000300004
dc.identifier10.1007/s11046-011-9404-z
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/65758
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/65758
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1273513
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.descriptionCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.descriptionProteinases produced by Candida albicans are one kind of virulence factor expressed that contribute to adherence and invasion of host tissue. Proteinase inhibitor of human immunodeficiency virus in experimental candidiasis suggested reduction in fungal infection, and medicinal plants could be a source of alternative agent to prevent diseases. In this study, we investigated the production of proteinases by C. albicans from clinical isolates and the action of plant extracts against strains of C. albicans and its synthesized proteinases, comparing with antifungal fluconazole and amphotericin B and proteinase inhibitors pepstatin A, amprenavir, and ritonavir. The results reported here showed that these extracts have a certain kind of action and that the search for new antifungal agents could be found at the plants.
dc.description172
dc.description2
dc.description117
dc.description124
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.descriptionCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.descriptionCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.languageen
dc.publisherSpringer
dc.publisherDordrecht
dc.publisherHolanda
dc.relationMycopathologia
dc.relationMycopathologia
dc.rightsfechado
dc.rightshttp://www.springer.com/open+access/authors+rights?SGWID=0-176704-12-683201-0
dc.sourceWeb of Science
dc.subjectAntifungal
dc.subjectCandida
dc.subjectMedicinal plants
dc.subjectProtease inhibitors
dc.subjectProteinases
dc.subjectHiv-infected Patients
dc.subjectIn-vitro
dc.subjectEssential Oils
dc.subjectAntimicrobial Activity
dc.subjectAspartyl Proteinases
dc.subjectProtease Inhibitors
dc.subjectAcid Proteinase
dc.subjectGene Family
dc.subjectAntibacterial
dc.subjectSusceptibility
dc.titleEvaluation of Antifungal Activity of Medicinal Plant Extracts Against Oral Candida albicans and Proteinases
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución